This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the irish market:
Product | Active Ingredient(s) |
Entecavir Accord 0.5mg Film Coated Tablets EU/1/17/1211/001 Accord Healthcare S.L.U. | Entecavir |
Estradot 50 micrograms/24 hours, transdermal patch PA0896/010/002 Novartis Ireland Limited | Estradiol |
Keflex 125mg/5ml Powder for Oral Suspension PA1226/002/002 Flynn Pharma Limited | Cefalexin |
Keflex 250mg/5ml Powder for Oral Suspension PA1226/002/003 Flynn Pharma Limited | Cefalexin |
Lanoxin PG 50 micrograms/ml Elixir PA1691/001/002 Aspen Pharma Trading Limited | Digoxin |
Logynon Tablets PA1410/005/001 Bayer Limited | Levonorgestrel & ethinylestradiol |
Lyclear 5% w/w Dermal Cream PA1077/066/001 GlaxoSmithKline (Ireland) Limited | Permethrin |
Solpadeine Tablets PA1186/011/003 Chefaro Ireland DAC | Paracetamol, codeine & caffeine |
Valsartan/Hydrochlorothiazide Teva 160mg/12.5mg Film Coated Tablets PA0749/047/003 Teva Pharma B.V. | Valsartan & hydrochlorothiazide |
Zonegran 100mg Capsules EU/1/04/307/004 Amdipharm Limited | Zonisamide |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
Product | Active Ingredient(s) |
Co-Amoxiclav TEVA 500mg/100mg Powder for Solution for Injection/Infusion PA0749/011/001 Teva Pharma B.V. | Amoxicillin & clavulanic acid |
Cozatan 50mg Film Coated Tablets PA0126/167/001 Clonmel Healthcare Limited | Losartan |
Creon 25000 Gastro Resistant Capsules PA23355/006/002 Viatris Healthcare Limited | Pancreas powder, lipase, amylase & protease |
Dexmedetomidine Accord 100mcg Concentrate for Solution for Infusion EU/1/19/1418/010 Accord Healthcare S.L.U. | Dexmedetomidine |
Erwinase 10 000 U Powder for Solution for Injection/Infusion PA23208/001/001 Porton Biopharma Limited | Crisantaspase |
Icatibant Accord 30mg Solution for infusion in pre-filled syringe EU/1/21/1567/001 Accord Healthcare S.L.U. | Icatibant |
Kay-Cee-L Syrup 7.5% w/v PA22637/004/001 Elara Pharmaservices Europe Limited | Potassium chloride |
Memantine Clonmel 10mg Film Coated Tablets 28 pack PA0126/255/002 Clonmel Healthcare Ltd | Memantine |
Memantine Clonmel 10mg Film Coated Tablets 56 pack PA0126/255/002 Clonmel Healthcare Ltd | Memantine |
NASONEX 50 micrograms/actuation Nasal Spray, Suspension PA23198/011/001 Organon Pharma (Ireland) Limited | Mometasone furoate |
Neotigason 10mg Capsules PA1986/113/001 Teva B.V. | Acitretin |
Paclitaxel 6mg/ml Concentrate for Solution for Infusion 50ml presentation PA2315/180/001 Accord Healthcare Ireland Ltd. | Paclitaxel |
Palonosetron 250 micrograms Solution for Injection PA2059/014/001 Fresenius Kabi Deutschland GmbH | Palonosetron |
Palonosetron 250 micrograms Solution for Injection in pre-filled syringe PA2059/014/002 Fresenius Kabi Deutschland GmbH | Palonosetron |
Pantoprazole Noridem 40mg Powder for Solution for Injection PA1122/011/001 Noridem Enterprises Limited | Pantoprazole |
Remifentanil Noridem 2mg Powder for Concentrate for Solution for Injection or Infusion PA1122/014/002 Noridem Enterprises Limited | Remifentanil |
Suprax 200mg Film Coated Tablets PA1142/042/001 Amdipharm Limited | Cefixime |
Trandate 200mg Film Coated Tablets PA1638/006/003 RPH Pharmaceuticals AB | Labetalol |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.